uric acid has been researched along with CKD-MBD in 5 studies
Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.
| Excerpt | Relevance | Reference |
|---|---|---|
| "These data suggest that factors other than uric acid may play a more important role in the regulation of CKD- MBD including vascular calcification and vitamin D metabolism in patients with CKD." | 9.27 | Examining the effects of uric acid-lowering on markers vascular of calcification and CKD-MBD; A post-hoc analysis of a randomized clinical trial. ( Andrews, ES; Chonchol, M; Jalal, D; Kendrick, J; Nowak, KL; Pasch, A; Perrenoud, L; You, Z, 2018) |
| " Furthermore, the findings in the index case present interesting novel aspects, including a previously undescribed coexistence of the 3-kb STX16 deletion and AHO-like features and a clinical course complicated by concomitant 25-[OH]-vitamin D deficiency, which may have resulted, at least partly, from long-term use of antiepileptic drugs." | 5.35 | Molecular diagnosis and clinical characterization of pseudohypoparathyroidism type-Ib in a patient with mild Albright's hereditary osteodystrophy-like features, epileptic seizures, and defective renal handling of uric acid. ( Babaoglu, M; Bastepe, M; Bayraktar, M; Harmanci, A; Unluturk, U; Varli, K; Yasar, U, 2008) |
| "These data suggest that factors other than uric acid may play a more important role in the regulation of CKD- MBD including vascular calcification and vitamin D metabolism in patients with CKD." | 5.27 | Examining the effects of uric acid-lowering on markers vascular of calcification and CKD-MBD; A post-hoc analysis of a randomized clinical trial. ( Andrews, ES; Chonchol, M; Jalal, D; Kendrick, J; Nowak, KL; Pasch, A; Perrenoud, L; You, Z, 2018) |
| " We calculated the mean values for proteinuria and serum phosphate, calcium, uric acid, and PTH, as well as 24-hour urinary excretion of urea nitrogen over time for each patient." | 3.79 | Factors related with the progression of chronic kidney disease. ( Abad, S; Ampuero, J; Aragoncillo-Sauco, I; Barraca, D; López-Gómez, JM; Ruiz-Caro, C; Vega-Martínez, A; Verdalles-Guzmán, Ú; Yuste, C, 2013) |
| " Furthermore, the findings in the index case present interesting novel aspects, including a previously undescribed coexistence of the 3-kb STX16 deletion and AHO-like features and a clinical course complicated by concomitant 25-[OH]-vitamin D deficiency, which may have resulted, at least partly, from long-term use of antiepileptic drugs." | 1.35 | Molecular diagnosis and clinical characterization of pseudohypoparathyroidism type-Ib in a patient with mild Albright's hereditary osteodystrophy-like features, epileptic seizures, and defective renal handling of uric acid. ( Babaoglu, M; Bastepe, M; Bayraktar, M; Harmanci, A; Unluturk, U; Varli, K; Yasar, U, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrews, ES | 1 |
| Perrenoud, L | 1 |
| Nowak, KL | 1 |
| You, Z | 1 |
| Pasch, A | 1 |
| Chonchol, M | 1 |
| Kendrick, J | 1 |
| Jalal, D | 1 |
| Afsar, B | 1 |
| Sag, AA | 1 |
| Oztosun, C | 1 |
| Kuwabara, M | 1 |
| Cozzolino, M | 1 |
| Covic, A | 1 |
| Kanbay, M | 1 |
| Yuste, C | 1 |
| Barraca, D | 1 |
| Aragoncillo-Sauco, I | 1 |
| Vega-Martínez, A | 1 |
| Abad, S | 1 |
| Verdalles-Guzmán, Ú | 1 |
| Ruiz-Caro, C | 1 |
| Ampuero, J | 1 |
| López-Gómez, JM | 1 |
| Unluturk, U | 1 |
| Harmanci, A | 1 |
| Babaoglu, M | 1 |
| Yasar, U | 1 |
| Varli, K | 1 |
| Bastepe, M | 1 |
| Bayraktar, M | 1 |
| Ferrari, R | 1 |
2 reviews available for uric acid and CKD-MBD
| Article | Year |
|---|---|
The role of uric acid in mineral bone disorders in chronic kidney disease.
Topics: Biomedical Research; Chronic Kidney Disease-Mineral and Bone Disorder; Fibroblast Growth Factor-23; | 2019 |
Rheumatologic manifestations of renal disease.
Topics: Calcium Phosphates; Calcium Pyrophosphate; Chronic Kidney Disease-Mineral and Bone Disorder; Crystal | 1996 |
1 trial available for uric acid and CKD-MBD
| Article | Year |
|---|---|
Examining the effects of uric acid-lowering on markers vascular of calcification and CKD-MBD; A post-hoc analysis of a randomized clinical trial.
Topics: Adolescent; Adult; Aged; Allopurinol; Carotid Intima-Media Thickness; Chronic Kidney Disease-Mineral | 2018 |
2 other studies available for uric acid and CKD-MBD
| Article | Year |
|---|---|
Factors related with the progression of chronic kidney disease.
Topics: Aged; Anemia; Calcium; Chronic Disease; Chronic Kidney Disease-Mineral and Bone Disorder; Diabetic N | 2013 |
Molecular diagnosis and clinical characterization of pseudohypoparathyroidism type-Ib in a patient with mild Albright's hereditary osteodystrophy-like features, epileptic seizures, and defective renal handling of uric acid.
Topics: Adolescent; Anticonvulsants; Base Sequence; Brain; Chronic Kidney Disease-Mineral and Bone Disorder; | 2008 |